Stephen Pham, Ph.D., is Senior Vice President, Product Development of Avalyn Pharma, Inc. Dr. Pham has over 25 years of industry experience in inhalation and ophthalmic products.

Prior to joining Avalyn, Dr. Pham served as a full-time consultant for Sunovion Pharmaceuticals where from Phase 2 through NDA submission and review, Dr. Pham was responsible for Lonhala® Magnair® product development (glycopyrrolate inhalation solution for maintenance treatment of COPD). Prior to Sunovion, he was Senior Director at Elevation Pharmaceuticals where he was responsible for Lonhala Magnair CMC until the Sunovion acquisition in 2012. Previously at Dey Laboratories (now Mylan), Dr. Pham was an inventor of Perforomist® (formoterol fumarate inhalation solution for maintenance treatment of COPD) and responsible for its development and approval. Dr. Pham was also an inventor of Bromsite® (bromfenac ophthalmic solution for post-operative ocular inflammation and pain).

Dr. Pham is well-published and holds over 20 published patents in formulation and drug delivery. He has a Ph.D. in pharmaceutics, an M.S. in theoretical chemistry, and a B.S. in chemistry, all from the University of Minnesota.